CHU [CHINA UNICOM (HONG KONG)] 6-K: (Original Filing)

[1 Announcement dated September 19, 2016 in respect of Operational Statistics for August 2016. • • changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC; • changes in telecommunications and related technologies and applications based on such technologies; • the level of demand for telecommunications services, in]

By | 2016-09-21T18:33:20+00:00 September 20th, 2016|Categories: Chinese Stocks, CHU, SEC Original|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic Receives CFDA Clinical Trial Approval for Human Coagulation Factor IX BEIJING, Sept. 19, 2016 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that Shandong Taibang Biological Products Co. Ltd., the Company's majority-owned subsidiary, recently obtained approval from the China Food and Drug] []

By | 2016-09-21T18:50:32+00:00 September 20th, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar